Morphine (Opioid Phenanthrene Alkaloid · WHO Essential Medicine · Informational Reference)
| Compound | Morphine |
| Chemical class | Alkaloid — Isoquinoline / Morphinan (Phenanthrene opioid alkaloid) |
| CAS | 57-27-2 |
| Primary source | Papaver somniferum (opium poppy capsule latex) |
| Key applications | Pharmaceutical opioid analgesic; Schedule II controlled substance; WHO Essential Medicine for severe pain; informational reference |
| Claim strength | High (as pharmaceutical); Informational only |
| Typical form | Pharmaceutical injection, oral tablet, oral solution; not a dietary supplement |
| Buy from Herbuno | Browse HerbIQ Compound Index → |
Name origin: Named after Morpheus, the Greek god of sleep and dreams — by Friedrich Sertürner who isolated it from opium in 1804–1806, the first isolation of a pharmacologically active alkaloid from a plant. This discovery marked the birth of alkaloid chemistry. Morphine is the primary phenanthrene opioid alkaloid of Papaver somniferum (opium poppy), constituting approximately 10–16% of dried opium by weight. Historical significance: Opium (the dried latex of P. somniferum) has been used for pain, sleep, and euphoria for at least 5,000 years — referenced in Sumerian clay tablets (~3400 BCE), the Ebers Papyrus (1550 BCE), and by Hippocrates. The isolation of morphine in 1804 by Sertürner transformed pain management and established pharmaceutical alkaloid chemistry as a discipline. The synthesis of morphine by Marshall Gates (1952) — one of the most complex alkaloid syntheses achieved at that time — is a landmark in synthetic organic chemistry. Pharmacology: Morphine is a full agonist at μ-opioid receptors (MOR), with weaker activity at κ- and δ-opioid receptors. MOR activation produces: analgesia (central and peripheral), respiratory depression (the primary lethal mechanism), euphoria (rewarding/addictive), constipation, and miosis. Morphine undergoes significant first-pass metabolism to morphine-6-glucuronide (M6G, active — more potent analgesic than morphine) and morphine-3-glucuronide (M3G, inactive, neuroexcitatory). Regulatory status: Schedule II controlled substance (US); Schedule 4/equivalent in most markets. WHO Essential Medicine for severe pain management. Not available as a dietary supplement in any jurisdiction.
Morphine — Pharmacological and Clinical Context
Mechanism — μ-opioid receptor agonism: Morphine binds μ-opioid receptors (GPCRs) in the dorsal horn of the spinal cord, periaqueductal grey (PAG), and peripheral nociceptors. Gi/o protein activation reduces cAMP, opens inwardly rectifying K+ channels (hyperpolarisation), and closes voltage-gated Ca2+ channels — collectively reducing neurotransmitter release and action potential propagation in pain pathways. This remains the gold standard mechanism for severe acute pain management. Pharmaceutical evidence: High.
Clinical applications (WHO Essential Medicine): Morphine is WHO-listed as essential for: severe acute pain (post-surgical, trauma), cancer pain (WHO pain ladder Step 3), palliative care dyspnoea, and myocardial infarction pain. Access to oral morphine for cancer pain remains severely limited in low-income countries — a major global health equity issue where 80% of the world’s population has inadequate access to opioid analgesics. Pharmaceutical evidence: High.
Addiction liability and opioid crisis context: Morphine’s euphoric effects via mesolimbic dopamine pathway activation (VTA → nucleus accumbens, mediated by disinhibition of dopaminergic neurons) underlie its addiction potential. The US opioid epidemic (beginning late 1990s with prescription opioid overprescribing, accelerating with illicit fentanyl) has caused over 500,000 opioid-related deaths. This public health catastrophe has fundamentally altered prescribing patterns, regulatory frameworks, and the scientific understanding of opioid risk. Critical public health reference.
This compound is documented for research and formulator education purposes. For commercially available botanical ingredients, explore the HerbIQ Compound Index →
Frequently Asked Questions — Morphine
What is the difference between morphine and heroin?
Heroin (diacetylmorphine) is morphine with two acetyl groups added to the 3- and 6-hydroxyl positions. The diacetylation increases lipophilicity approximately 100-fold, dramatically accelerating CNS penetration and producing a faster, more intense euphoric onset than morphine (the “rush”). Once in the brain, heroin is rapidly hydrolysed to 6-monoacetylmorphine and then morphine — making heroin essentially a rapidly-delivering morphine prodrug. Heroin was originally synthesised by Bayer AG in 1898 and marketed as a “non-addictive” morphine substitute and cough suppressant — one of the most consequential pharmaceutical misjudgements in history.
Why is morphine still used when newer opioids exist?
Morphine remains widely used because: (1) it is generic and inexpensive; (2) its pharmacology is the most extensively characterised of any opioid; (3) it is on the WHO Essential Medicines List; (4) its active metabolite M6G contributes meaningfully to analgesia; (5) dose titration is well-understood across patient populations. Newer opioids (hydromorphone, oxycodone, fentanyl, tapentadol) offer specific advantages in particular patient populations but have not replaced morphine as the reference opioid for severe pain.
What is the morphine equivalent dose system?
The morphine milligram equivalent (MME) system expresses all opioid doses as equivalent to a number of milligrams of oral morphine, enabling comparison across different opioids and routes of administration. Example: oral oxycodone 1 mg = 1.5 MME; oral hydromorphone 1 mg = 4 MME; transdermal fentanyl 25 μg/hr = ~50–60 MME/day. MME is used in opioid prescribing guidelines and risk stratification — doses above 90 MME/day are associated with significantly increased overdose risk and trigger mandatory risk mitigation in US prescribing guidelines.
Is morphine derived from the poppy plant commercially?
Yes — most pharmaceutical morphine is extracted from Papaver somniferum latex (opium) grown under international narcotics control treaties (Single Convention on Narcotic Drugs, 1961). Major licit producers include Tasmania (Australia), Spain, France, Turkey, and India. The International Narcotics Control Board (INCB) regulates global opium production quotas. Morphine is also the precursor from which most semi-synthetic opioids are manufactured (codeine, hydromorphone, oxycodone, hydrocodone via thebaine).
Related compounds: Codeine, Thebaine, Oripavine, Noscapine
Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.
← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery